KRKA is a generic pharmaceutical company, which engages in the development, production, marketing, and sale of prescription pharmaceuticals, non-prescription products, and animal health products. The Company's prescription pharmaceuticals include medicines for the treatment of cardiovascular diseases, central nervous system diseases, diseases of the alimentary tract and metabolism, infections, diseases of the blood and blood-forming organs, diseases of the urinary tract, diseases of the respiratory system, and oncology.